[Effect of cefaclor in urinary tract infections (2)]. 1984

H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani

A second part of our continuous investigation on the clinical effect of cefaclor (CCL) against urinary tract infections was reported herein. CCL, a daily dose of 0.75 g t.i.d., has been applied for the treatment of (I) 76 cases with the uncomplicated acute cystitis in the women, and (II) 55 cases with the complicated. Rates of effectiveness were obtained 98.7% in (I) and 60% in (II). Side effects were noted in 13 cases out of total 150 cases.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002433 Cefaclor Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-,Ceclor,Cefaclor Anhydrous,Cefaclor Monohydrate,Keclor,Lilly 99638,S-6472,S 6472,S6472
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani
August 1985, The Japanese journal of antibiotics,
H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani
July 1984, The American journal of emergency medicine,
H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani
April 1991, Antimicrobial agents and chemotherapy,
H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani
January 1979, Infection,
H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani
January 1992, Postgraduate medical journal,
H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani
July 1980, Acta urologica Belgica,
H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani
September 1991, Antimicrobial agents and chemotherapy,
H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani
January 1988, Clinical therapeutics,
H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani
November 1983, Antimicrobial agents and chemotherapy,
H Kajikawa, and S Hosokawa, and H Kameoka, and N Nishimoto, and S Miyoshi, and N Iwao, and S Mizutani
April 1984, The Japanese journal of antibiotics,
Copied contents to your clipboard!